Medical/Pharmaceuticals

Cedrus' Head of Life Sciences Invited to Moderate a Panel at China Focus@BIO and was a Panelist at the Redefining Early Stage Investments Conference in Philadelphia

HONG KONG, June 17, 2019 /PRNewswire/ -- Ms. Kimberly Nearing, Head of Life Sciences atCedrus Investments ("Cedrus") , was invited to moderate the first panel of the China Focus@BIO Conference in Philadelphia held on 2nd June 2019. Kim was also a panelist at the ...

2019-06-17 09:00 195

First Uzbekistani Company in Hong Kong to bring Chinese Medicine Business along "The Belt and Road"

HONG KONG, June 14, 2019 /PRNewswire/ -- On June 13, "The Belt and Road" International Cocktail Reception of Chinese Medicine Innovation and Cooperation was held inHong Kong by Yulin Bagu Group JV LLC. The event was attended by the delegation of H.E.Bakhtiyor Saidov, Ambassador of Uzbekistan in C...

2019-06-14 12:48 1936

China National Medical Products Administration Approves Sinovant's Clinical Trial Application for Lefamulin

-  Chinese registrational clinical trial for lefamulin to begin in 2H 2019 BEIJING and SHANGHAI, June 14, 2019 /PRNewswire/ -- Sinovant Sciences today announced that its Clinical Trial Application (CTA) for lefamulin has been accepted by the Center for Drug Evaluation at the China National Medica...

2019-06-14 09:00 1393

Avalon GloboCare President and CEO David Jin, M.D., Ph.D. to Chair the "Research and Application of Stem Cell Exosomes" Session at This Year's Second International Aesthetic Industry Conference

Avalon GloboCare to Unveil the Launch of its Exosome Product Commercialization Plan at the Second Aesthetic Industry Conference, the Largest Aesthetics Conference Across Asia Yu Zhou, M.D., Ph.D., Co-CEO of Avalon's subsidiary GenExosome Technologies to provide keynote address FREEHOLD, New Jer...

2019-06-13 20:00 3521

Tessa Therapeutics and China-Singapore Guangzhou Knowledge City Form Landmark US$120 Million Joint Venture in China to Develop Innovative Cell Therapies for Cancer

* The partnership will leverage Tessa Therapeutics' global operational capabilities and cell therapy platform technologies to target prevalent cancers inChina * The joint venture will be the sole licensee of Tessa Therapeutics' cell therapies for research, development and commercialization in...

2019-06-13 07:15 863

Oral semaglutide demonstrated cardiovascular safety in people with type 2 diabetes and established cardiovascular disease or high cardiovascular risk in PIONEER 6 trial

SAN FRANCISCO, June 12, 2019 /PRNewswire/ -- Novo Nordisk today announced that the PIONEER 6 trial achieved its primary endpoint by demonstrating non-inferiority of major adverse cardiovascular events (MACE) with oral semaglutide compared with placebo, both in addition to standard of care. The p...

2019-06-12 02:45 1254

Amcor Completes Acquisition of Bemis, Creating the Global Leader in Consumer Packaging

CHICAGO and MELBOURNE, Australia, June 12, 2019 /PRNewswire/ -- Amcor today announces the successful completion of its acquisition of Bemis Company Inc., effective11 June 2019. The combined company will now operate as Amcor plc (Amcor), trading on the New York Stock Exchange under the ticker symb...

2019-06-12 02:26 1201

Centinel Spine Announces Partnership with Tiger Woods

NEW YORK, June 11, 2019 /PRNewswire/ -- Centinel Spine®, LLC, the largest privately-held spine company focused on anterior column reconstruction, today announced an important partnership with one of the most winning professional athletes of all time, Tiger Woods. This partnership brings together ...

2019-06-11 21:12 1233

Zeus Expands Portfolio with New Polyimide Family of Products

Products Include PI Tubing, PI Coated Wire, PI Glide™ Tubing, and PI Glide™ Coated Wire ORANGEBURG, South Carolina, June 11, 2019 /PRNewswire/ -- Zeus Industrial Products, Inc. (Zeus), a leading polymer solutions provider and material science innovator, has announced the introduction of a newpol...

2019-06-11 20:00 930

Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2019 Financial Results

HONG KONG, June 11, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the fourth quarter and full year fiscal 2019 onTuesday, June 18, 2019, after the market close.  The Company will host a conference call...

2019-06-11 19:00 5171

TauRx Recognized as a Technology Innovation Leader in the Neurodegenerative Disease Management Industry

ABERDEEN, Scotland and SINGAPORE, June 11, 2019 /PRNewswire/ -- TauRx, a leader in neurodegenerative disease research, today announced that it is the recipient of Frost & Sullivan's 2019 Asia Pacific Neurodegenerative Disease Management Technology Innovation Award.

2019-06-11 08:00 1039

Inovio Receives $8.14 Million Award to Support Further Development of its Commercial Skin Delivery Device

PLYMOUTH MEETING, Pennsylvania, June 10, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today that the medical arm of the U.S. Defense Threat Reduction Agency (DTRA) will fund the further development of Inovio's new commercial intradermal delivery device. DTRA's Medical ...

2019-06-10 21:00 1273

Avalon GloboCare Announces Completion of Clinical-Grade Exosome Bio-Production Standardization with Launch of "ACTEX" Product Commercialization

This milestone marks a pivotal point in Avalon's pipeline, now allowing the company to enter its next phase of commercializing clinical-grade exosome products FREEHOLD, New Jersey, June 10, 2019 /PRNewswire/ -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of cell-based techn...

2019-06-10 20:00 6000

Ping An Good Doctor Launches Groundbreaking 'Private Doctor' Service

Strategic Move to Introduce Customized Mobile Medical Services SHANGHAI, June 10, 2019 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited("Ping An Good Doctor", or the "Company"; stock code: 01833.HK), the world's leading one-stop healthcare ecosystem platform, has launched the...

2019-06-10 12:32 6525

Oral semaglutide showed superior reductions in blood sugar vs Jardiance® and non-inferior blood sugar reductions vs Victoza® in adults with type 2 diabetes at 26 weeks

Abstracts 54-OR and 55-OR Secondary data at 52 weeks demonstrated statistically significant blood sugar reductions and statistically significant reduction of body weight vs both Jardiance® and Victoza® SAN FRANCISCO, June 8, 2019 /PRNewswire/ -- Findings presented today from two phase 3a clinic...

2019-06-08 23:45 2238

ESPGHAN Researchers Warn: Junk Food Could Be Responsible for the Food Allergy Epidemic

GLASGOW, Scotland, June 8, 2019 /PRNewswire/ -- Experts at the 52nd Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) are today presenting research that shows higher levels of advanced glycation end products (AGEs), found in abundance in ju...

2019-06-08 07:01 2900

Asia's Leading Companies Celebrated at the 2019 Frost & Sullivan Asia-Pacific Best Practices Awards

SINGAPORE, June 7, 2019 /PRNewswire/ -- Frost & Sullivan named some of Asia's leading companies recognized for their achievements in its recipients list for the Asia-Pacific Best Practices Awards earlier today. Mr. Shivaji Das, Partner & Asia-Pacific Managing Director at Frost & Sullivan noted t...

2019-06-07 23:23 4092

Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal

HONG KONG, June 6, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-binding proposal l...

2019-06-06 18:00 11785

Innovent provides Update on the Results of Sintilimab for the Treatment of Extranodal NK/T Cell Lymphoma by Oral Presentation at ASCO

SUZHOU, China, June 5, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the research data on the treatment of relapsed or refractory extranodal NK/T cell ly...

2019-06-05 08:00 1835

RemeGen, Ltd. Announces Positive Results from RC48 Clinical Trial in HER2-Positive Metastatic or Unresectable Urothelial Cancer

Results, presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting, demonstrated clinically meaningful response in patients with urothelial carcinoma whose treatment previously failed, a population with high unmet medical need YANTAI, China, June 4, 2019 /PRNewswire/ -- R...

2019-06-04 21:00 1892
12345 ... 115